Rev Esp Quimioter 2018; 31(3):247-256

Results of the implementation of an Antimicrobial Stewardship Program in the “Gerencia de Atención Integrada” of Alcazar de San Juan (Castilla La Mancha)

MARÍA ÁNGELES ASENCIO EGEA, ÓSCAR HERRÁEZ CARRERA, MARÍA HUERTAS VAQUERO, HUGO DANIEL PATIÑO ORTEGA, MARÍA FRANCO HUERTA, PATRICIA ALCÁZAR CARMONA, MARÍA CARMEN CONDE GARCÍA, CRISTINA MUÑOZ-CUEVAS, CARMEN ROMÁN ORTIZ, JORGE GAITÁN PITERA, RAFAEL CARRANZA GONZÁLEZ, JOSÉ RAMÓN BARBERÁ

Introduction. Our aim was to evaluate the efficiency of an ASP after its implementation in 2016 in a Spanish hospital quality system.
Material and methods. Efficiency of the ASP was measured by process and outcome indicators at the level of the patient’s quality of life, antimicrobial consumption and percentage of resistance to them during the 2016-2017 period. In 2017, the failures mode and effects analysis (FMEA) methodology was applied. An annual satisfaction survey was conducted.
Results. The clinical indicators were within the threshold of acceptability, as well as the empirical prescription of antimicrobials, the consumption of antibiotics (reduction of 77 DDD in the first semester of 2016 to 26 in the second semester of 2017) and the renal (gentamicin) and neurological (carbapenems) toxicity. The FMEA identified as a main risk the lack of adequacy of the empirical treatment once the antibiogram was obtained; thus, a corrective action was taken in 2017. Regarding the microbiological indicators, the incidence of multi-drug resistant and carbapenemase-producing enterobacteria, and that of methicillin-resistant Staphylococcus aureus, were reduced. Eighty-three percent of the counselling activities carried out were accepted. The surveys revealed a good acceptance and spread of the program, the need for protocols and training in the use of antibiotics.
Conclusions. The implementation of the ASP in the quality system was efficient. The consumption of antibiotics and the adverse effects derived from their use were reduced, improving the quality of life of patients, and reducing health costs.

Rev Esp Quimioter 2018; 31(3):247-256 [Texto completo PDF]